Patterned Peptide Microarrays for Antibody Characterization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunotherapy and antibody-based cancer treatments face challenges due to limited patient response rates, high development costs, and increased financial burdens on patients, largely attributed to off-target side effects and the high cost of R&D, which restricts the number of candidates and market competition.
Innovation Solution
A scalable peptide library platform utilizing merged peptide synthesis chemistry and semiconductor manufacturing processes to pattern over 40 million peptides on a wafer, enabling comprehensive antibody characterization and reducing off-target risks through high-throughput screening and characterization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If comprehensive antibody characterization and high-throughput screening are implemented to reduce off-target risks, then treatment efficacy and safety are improved, but development costs and complexity increase
Solution Approach 1:
The patent segments the comprehensive screening process into multiple parallel microarray assays, each targeting specific protein families or pathways. This allows systematic evaluation of off-target effects across different biological categories while maintaining manageable complexity through modular assay design and automated analysis pipelines.
Solution Approach 2:
The patent employs universal screening platforms that can evaluate multiple antibody candidates against diverse protein targets using standardized protocols. The microarray-based system serves multiple functions including binding affinity measurement, epitope mapping, and cross-reactivity assessment, reducing the need for separate specialized assays for each characterization type.
2Adaptability or versatility
If the number of antibody candidates in the discovery pipeline is increased to enhance market competition, then innovation and competition are improved, but R&D costs increase
Solution Approach 1:
The patent implements preliminary high-throughput screening and characterization of antibody candidates early in the discovery pipeline using microarray assays. This preliminary action identifies and eliminates candidates with problematic off-target effects before significant resource investment in later development stages, enabling more candidates to progress through the pipeline cost-effectively.
Solution Approach 2:
The patent uses microarray technology to create replicated arrays of protein targets and antibody candidates, enabling simultaneous evaluation of multiple candidates against multiple targets. This copying approach allows parallel screening of numerous candidates, effectively increasing the throughput and reducing the per-candidate cost of characterization.
3Productivity
If R&D cycle-time is reduced to increase productivity, then productivity is improved, but measurement precision and characterization completeness may deteriorate
Solution Approach 1:
The patent implements periodic, iterative screening cycles where antibody candidates are evaluated across multiple rounds of microarray assays. Each cycle focuses on different aspects of characterization (binding affinity, specificity, cross-reactivity), allowing comprehensive evaluation to be distributed across time rather than requiring all measurements to be completed simultaneously, thus maintaining precision while improving overall throughput.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the detection of therapeutic antibody interactions, reduces development costs, and enhances the number of candidate molecules, thereby improving treatment efficacy and market competition while minimizing off-target effects.
Implementation Method 1
The method comprises: (a) receiving an input amino acid sequence; (b) determining a plurality of photomasks, each photomask having a pattern corresponding to an activated or inactivated designation to each feature on the substrate
Implementation Method 2
assigning at least one monomer to each photomask; and (d) coupling the monomers onto the features to form peptides
Data Source
AI summary
Provided herein are methods, chemical library and simulation system for performing in situ patterned chemistry. Methods, systems and assays comprising the use of the synthesized chemical libraries, which increase explored protein space in a knowledge-based manner, are also provided for characterizing antibody-target interactions including: identifying target proteins of antibodies, characterizing antibody-binding regions in target proteins, identifying linear and structural epitopes in target proteins, and determining the propensity of antibody binding to target proteins.